| MYL | Mylan N.V. | 17.27 | 0.00 | +0.03% | 3,573,051 |
| TOCA | Tocagen Inc. | 0.5805 | -0.0008 | -0.14% | 110,528 |
| AMGN | Amgen Inc. | 224.93 | 0.43 | +0.19% | 1,748,686 |
| RTRX | Retrophin, Inc. | 13.00 | 0.05 | +0.39% | 233,326 |
| HALO | Halozyme Therapeutics, Inc. | 19.07 | -0.08 | -0.42% | 1,323,238 |
| BLUE | bluebird bio, Inc. | 74.46 | 0.46 | +0.62% | 810,995 |
| FLXN | Flexion Therapeutics, Inc. | 16.58 | 0.14 | +0.85% | 251,878 |
| XLRN | Acceleron Pharma Inc. | 42.81 | -0.38 | -0.88% | 365,269 |
| CERS | Cerus Corporation | 4.3700 | 0.0500 | +1.16% | 631,983 |
| ILMN | Illumina, Inc. | 314.81 | 3.80 | +1.22% | 484,973 |
| FOLD | Amicus Therapeutics, Inc. | 9.64 | -0.12 | -1.23% | 1,999,029 |
| INSM | Insmed Incorporated | 20.37 | -0.29 | -1.40% | 742,371 |
| ADVM | Adverum Biotechnologies, Inc. | 9.76 | 0.15 | +1.56% | 643,644 |
| ANIP | ANI Pharmaceuticals, Inc. | 57.50 | 0.94 | +1.66% | 56,163 |
| EIDX | Eidos Therapeutics, Inc. | 56.44 | -1.15 | -1.99% | 342,189 |
| CNCE | Concert Pharmaceuticals, Inc. | 6.95 | 0.14 | +2.06% | 122,663 |
| FOMX | Foamix Pharmaceuticals Ltd. | 3.3300 | -0.0700 | -2.06% | 312,600 |
| TBIO | Translate Bio, Inc. | 10.88 | 0.23 | +2.16% | 301,048 |
| NVCR | NovoCure Limited | 90.52 | 2.08 | +2.35% | 918,254 |
| MEDP | Medpace Holdings, Inc. | 74.50 | 2.01 | +2.77% | 190,995 |
| ARQL | ArQule, Inc. | 8.72 | 0.26 | +3.01% | 1,681,302 |
| EDIT | Editas Medicine, Inc. | 24.16 | -0.80 | -3.21% | 589,031 |
| AGLE | Aeglea BioTherapeutics, Inc. | 8.27 | 0.27 | +3.31% | 63,967 |
| NERV | Minerva Neurosciences, Inc. | 5.74 | 0.18 | +3.33% | 273,716 |
| XON | Intrexon Corporation | 6.03 | 0.22 | +3.87% | 1,471,739 |
| OPTN | OptiNose, Inc. | 11.05 | 0.46 | +4.34% | 246,192 |
| PGNX | Progenics Pharmaceuticals, Inc. | 5.50 | -0.28 | -4.84% | 345,717 |
| AKCA | Akcea Therapeutics, Inc. | 20.80 | 1.72 | +9.01% | 334,445 |
| PACB | Pacific Biosciences of California, Inc. | 5.34 | 0.66 | +13.99% | 5,189,638 |
| SURF | Surface Oncology, Inc. | 2.0600 | 0.6200 | +43.06% | 450,245 |